Griggs Chloe, Jensen Jan
Shepway Primary Care Trust, Kent, UK.
J Adv Nurs. 2006 May;54(4):491-501. doi: 10.1111/j.1365-2648.2006.03837.x.
The aim of this paper is to evaluate previous research studies on acupuncture for migraine with reference to the Standards for Reporting Interventions in Controlled Trials of Acupuncture guidelines.
It is estimated that around 2-15% of the world's population are affected by migraine headaches. Thirteen per cent of adults in the United Kingdom suffer with chronic pain, migraine headaches accounting for 7% of cases. Migraine pain relief is grounded in pharmacology. Acupuncture for migraine has been widely researched. However, inconsistent and low quality results have been produced. Recently, published Standards for Reporting Interventions in Controlled Randomized Trials of Acupuncture guidelines recommend important information that must be included in research in order to be valid and reliable.
Searches were conducted between September 2003 and May 2004 using the Ovid Medline 1966-2004, British Medical Journal, Blackwell Synergy, Science Direct, The Lancet and Cochrane Library Issue 1 databases. Searches were limited to the previous 20 years and to publications in the English language only.
Thirteen randomized controlled trials met the inclusion criteria and were critically reviewed for methodological quality, reporting of acupuncture needling details, practitioner background, control interventions and use of a diagnostic criterion. Findings agreed with previous literature reviews that the majority of studies of acupuncture for migraine research are of poor quality, with conflicting results. Few studies met the criteria of the Standards for Reporting Interventions in Controlled Trials of Acupuncture recommendations. Overall, the quality of research in this area must be questioned.
In the light of these findings, practitioners may face a dilemma when considering the use of acupuncture for migraine. Therefore, large, high quality randomized controlled trials of acupuncture for migraine are needed. Until better quality research is published, with verification of the benefits of acupuncture for migraine, provision of this alternative therapy should not be expanded or withdrawn.
本文旨在参照《针刺对照试验干预措施报告标准》指南，评估以往关于针刺治疗偏头痛的研究。
据估计，全球约2% - 15%的人口受偏头痛困扰。英国13%的成年人患有慢性疼痛，其中偏头痛占7%。偏头痛疼痛缓解基于药理学。针刺治疗偏头痛已得到广泛研究。然而，研究结果不一致且质量较低。最近发布的《针刺对照随机试验干预措施报告标准》指南推荐了研究中必须包含的重要信息，以确保研究有效且可靠。
于2003年9月至2004年5月期间，使用Ovid Medline 1966 - 2004、《英国医学杂志》、Blackwell Synergy、Science Direct、《柳叶刀》和Cochrane图书馆第1期数据库进行检索。检索限于过去20年且仅为英文出版物。
13项随机对照试验符合纳入标准，并对其方法学质量、针刺细节报告、从业者背景、对照干预措施及诊断标准的使用进行了严格审查。结果与以往文献综述一致，即大多数针刺治疗偏头痛的研究质量较差，结果相互矛盾。很少有研究符合《针刺对照试验干预措施报告标准》的推荐标准。总体而言，该领域的研究质量令人质疑。
鉴于这些发现，从业者在考虑使用针刺治疗偏头痛时可能会面临两难境地。因此，需要开展大规模、高质量的针刺治疗偏头痛随机对照试验。在发表质量更高的研究并证实针刺治疗偏头痛的益处之前，不应扩大或停止提供这种替代疗法。
